Vancouver, British Columbia – October 1, 2026 – TheNewswire - Frequency Exchange Corp. (TSXV: FREQ) (OTCQB: FRECF) (FSE: YC6) (“Frequency Exchange” or the “Company”) is pleased to highlight the upcoming global premiere of Superhuman 2: The Rebirth, the new four‑part docuseries from award‑winning filmmaker Caroline Cory. The production debuted as an Official Selection of the DaVinci International Film Festival on September 26, 2026, which will be followed by a red‑carpet global premiere at the Saban Theatre in Beverly Hills on October 4, 2026, and worldwide digital release scheduled October 30, 2026.

NIKKI Wellness Technology, Frequency Exchange’s flagship frequency‑based wellness platform and wearable device, is the production’s principal partner. NIKKI is prominently featured throughout the docuseries as a leading innovator in emerging wellness technology. The film introduces audiences to novel approaches in optimizing human potential, performance, and wellness—providing Frequency Exchange with a meaningful visibility milestone as it advances commercialization across North America, the Middle East, and other international markets.

Stephen Davis, CEO of Frequency Exchange, commented: “The premiere of Superhuman 2: The Rebirth places NIKKI at the forefront of wellness technology at a pivotal moment in our commercial rollout. We believe this exposure will support our global expansion efforts and strengthen market awareness as demand for frequency‑based wellness solutions continues to grow.”

The increased visibility comes as Frequency Exchange continues to advance the commercialization of NIKKI and its previously announced non-brokered private placement offering (the “Offering”). The Offering provides investors the opportunity to participate at a unit price of $0.25, with each unit consisting of one common share and one‑half common share purchase warrant. Each whole warrant is exercisable at $0.40 for a period of 12 months from issuance, subject to an acceleration clause.

To accommodate continued investor interest and allow additional time to finalize subscriptions for the second tranche, the Company has received approval from the TSX Venture Exchange to extend the closing date of the Offering to October 31, 2026.

As previously announced on September 11, 2026, the Company closed the first tranche of the Offering, issuing 1,708,230 units for gross proceeds of $427,057. Each unit consisted of one common share and one-half of one common share purchase warrant.

About Superhuman 2: The Rebirth

Superhuman 2: The Rebirth is a four‑part investigative docuseries by award‑winning filmmaker Caroline Cory that examines emerging scientific perspectives on human potential, perception, and cognitive performance. As outlined on superhuman2.com, the series uses structured experiments and interviews to explore phenomena that challenge conventional models of cognition and sensory processing, providing viewers with a research‑driven look at evolving wellness approaches in the field.

NIKKI Wellness Technology is prominently integrated throughout the docuseries as an emerging wellness technology. Its integration offers audiences additional context on frequency‑based wellness programs within real‑world observational settings, aligning with the background provided at wearenikki.com/superhuman. The production’s global release supports broader visibility as Frequency Exchange advances commercialization initiatives.

About Frequency Exchange Corp.

Frequency Exchange Corp. (TSXV: FREQ | OTCQB: FRECF | FSE: YC6) is a technology company developing the next generation of wearable digital wellness solutions through its NIKKI platform. NIKKI delivers proprietary frequency‑based wellness programs designed to support sleep, stress, recovery, energy, and overall wellbeing. For more information, visit www.frequencyexchangecorp.com or www.wearenikki.com.

 

Investor Contacts

Frequency Exchange Corp.                         FREmedica Technologies Inc.
Stephen Davis          Nicole Sullivan
Chief Executive Officer        President
stephen@frequencyexchangecorp.com                 nicole.sullivan@wearenikki.com
604‑684‑2181         604‑684‑2181

Forward‑Looking Information

This press release contains forward‑looking information and forward‑looking statements within the meaning of applicable Canadian securities legislation. Such statements include, but are not limited to, statements regarding the timing and scope of the Company’s commercialization activities, product launches, retail initiatives, international expansion, events, exposure through Superhuman 2: The Rebirth, completion of the Company’s financing, use of proceeds, inventory, distribution, and future growth.

Forward‑looking statements are based on management’s current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Readers are cautioned not to place undue reliance on forward‑looking statements. The Company undertakes no obligation to update such statements except as required by applicable securities laws.

Additional information identifying risks and uncertainties is contained in filings by the Company with the Canadian securities regulators, which filings are available under the Company’s profile on SEDAR+ at www.sedarplus.ca.

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.